Skip to main content
Log in

Therapeutic effects of supplementation with Curcuminoids in critically ill patients receiving enteral nutrition: a randomized controlled trial protocol

  • Study Protocol
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

Curcuminoids are dietary polyphenols that can improve health indices through different mechanisms such as anti-inflammatory, antioxidant and immunoregulatory properties. Due to the lack of evidences on the efficacy of curcuminoids in critically ill patients, this study was designed to investigate the effects of short-term curcuminoids supplementation on inflammatory, oxidative stress and adipokine indices as well as nutritional and clinical status in Traumatic Brain Injury (TBI) patients admitted in the Intensive Care Unit (ICU).

Methods

The present trial will be performed in the ICU of Sina and Shohadaye Tajrish hospitals of Tehran, Iran. Sixty-two critically ill patients with TBI will be enrolled based on the eligibility criteria. The patients will be randomly assigned into two groups. For 7 days, they will received either 500 mg curcuminoids in combination with 5 mg piperine or matched placebo. A general questionnaire, consent form as well as NUTRIC, SOFA and APACHEII scoring system and anthropometrics will be assessed at baseline. The inflammatory markers including TNF-α, IL-6, MCP-1 and CRP, oxidative stress indices (GPx and SOD) and adipokines (leptin and adiponetctin) will be measured at baseline and at the end of the study. In addition, dietary intake, concomitant drugs and laboratory tests will be recorded daily.

Discussion

To the best of our knowledge, this is the first clinical trial investigating the effect of curcuminoids supplementation in critically ill patient with TBI. The findings of the present study will provide evidence on the efficacy and safety of curcuminoids in these patients.

Trial registration number

(http://www.irct.ir, identifier: IRCT20180619040151N1), Registration date:18.09.2018.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

TBI:

Traumatic brain injury

ICU:

Intensive care unit

TNF-α:

Necrosis factor-α

IL-6:

Interleukine-6

MCP-1:

Monocyte chemoattractant protein-1

CRP:

C-reactive protein

APACHEII:

Acute physiology and chronic health evaluation II

SOFA:

Sequential organ failure assessment

NUTRIC:

Nutrition risk in the criticallay ill

SDH:

Acute subdural hematoma

ICH:

Intracranial hemorrhage

DAI:

Diffuse axonal injury

NF- kB:

Nuclear factor-kappa B

Nrf2:

Nuclear factor erythroid 2-related factor 2

GPx:

Gluthation peroxidase

SOD:

Superoxide dismutase

GCS:

Glascow coma score

BMI:

Body mass index

GRAS:

Generally recognized as safe

FDA:

Food and Drug Adminstration

ELISA:

Enzymed-linked immunosorbent Assay

ANOVA:

Analysis of variance (ANOVA).

References

  1. Plesnila N. The immune system in traumatic brain injury. Curr Opin Pharmacol. 2016;26:110–7.

    Article  CAS  Google Scholar 

  2. Young LA, Rule GT, Bocchieri RT, Burns JM. Biophysical mechanisms of traumatic brain injuries. Semin Neurol. 2015;35(1):5–11.

    Article  Google Scholar 

  3. Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat. 2015;11:97–106.

    PubMed  PubMed Central  Google Scholar 

  4. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728–41.

    Article  Google Scholar 

  5. Finfer SR, Cohen J. Severe traumatic brain injury. Resuscitation. 2001;48(1):77–90.

    Article  CAS  Google Scholar 

  6. Polinder S, Meerding WJ, Mulder S, Petridou E, van Beeck E. Assessing the burden of injury in six European countries. Bull World Health Organ. 2007;85(1):27–34.

    Article  Google Scholar 

  7. Fakharian E, Mohammadzadeh M, Behdadmehr S, Sabri HR, Mirzadeh AS, Mohammadzadeh J. Repetitive traumatic brain injury in patients from Kashan. Iran Trauma Monthly. 2016;21(4):e23869.

    PubMed  Google Scholar 

  8. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008;25(7):719–38.

    Article  Google Scholar 

  9. Raj R, Skrifvars M, Bendel S, Selander T, Kivisaari R, Siironen J, et al. Predicting six-month mortality of patients with traumatic brain injury: usefulness of common intensive care severity scores. Crit Care (London, England). 2014;18(2):R60.

    Article  Google Scholar 

  10. Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Critical care (London, England). 2011;15(6):R268.

    Article  Google Scholar 

  11. Deguchi A. Curcumin targets in inflammation and cancer. Endocrine, Metab Immune Disord Drug Targets. 2015;15(2):88–96.

    Article  CAS  Google Scholar 

  12. Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin Nutrit (Edinburgh, Scotland). 2015;34(6):1101–8.

    Article  CAS  Google Scholar 

  13. Panahi Y, Alishiri GH, Parvin S, Sahebkar A. Mitigation of systemic oxidative stress by Curcuminoids in osteoarthritis: results of a randomized controlled trial. J Diet Supplements. 2016;13(2):209–20.

    Article  CAS  Google Scholar 

  14. Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167–75.

    Article  Google Scholar 

  15. Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nat Rev Cardiol. 2014;11(2):123.

    Article  CAS  Google Scholar 

  16. Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of non-alcoholic fatty liver disease with Curcumin: a randomized placebo-controlled trial. Phytotherapy research : PTR. 2016;30(9):1540–8.

    Article  CAS  Google Scholar 

  17. Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. BioFactors (Oxford, England). 2013;39(1):2–13.

    Article  CAS  Google Scholar 

  18. Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72(3):355–62.

    Article  Google Scholar 

  19. Calabrese V, Bates TE, Mancuso C, Cornelius C, Ventimiglia B, Cambria MT, et al. Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res. 2008;52(9):1062–73.

    Article  CAS  Google Scholar 

  20. Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169(8):1672–92.

    Article  CAS  Google Scholar 

  21. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 2000;28(8):1303–12.

    Article  CAS  Google Scholar 

  22. Panahi Y, Hosseini MS, Khalili N, Naimi E, Soflaei SS, Majeed M, et al. Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial. Nutrition (Burbank, Los Angeles County, Calif). 2016;32(10):1116–22.

    Article  CAS  Google Scholar 

  23. Rahimnia AR, Panahi Y, Alishiri G, Sharafi M, Sahebkar A. Impact of supplementation with Curcuminoids on systemic inflammation in patients with knee osteoarthritis: findings from a randomized double-blind placebo-controlled trial. Drug Res. 2015;65(10):521–5.

    CAS  Google Scholar 

  24. Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules (Basel, Switzerland). 2011;16(6):4567–98.

    Article  CAS  Google Scholar 

  25. Goel A, Jhurani S, Aggarwal BB. Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res. 2008;52(9):1010–30.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The support of Tehran University of Medical Sciences and Semnan University of Medical Sciences and Health Services and cooperation of the Sina and Shohadaye Tajrish hospitals as well as patient advisers are acknowledged.

Funding

The present research has been supported by Tehran University of Medical Sciences and Semnan University of Medical sciences and Health Services grant no. 96–04–161-37823.

Author information

Authors and Affiliations

Authors

Contributions

Ablodreza Norouzy cooperated on the initial study concept and design of this research, which was further developed by Mahdi Shadnoush and Mohammad-Javad Hosseinzadeh-Attar. Saeed Hoseeini revised the study. Mostafa Qorbani advised on statistical analysis and interpretation of data. Atabak Najafi, Arezoo Ahmadi and Seyed-Hoseein Ardehali coordinated participant management and data collection and relevant questionnairs. Hoda Zahedi and Amirhossein Sahebkar took part in drafting the manuscript and technical or material support. Hamideh Moravvej and Gholamreza Pourmand will corporate in laboratory activities. The manuscript has been read and approved by all authors.

Corresponding authors

Correspondence to Abdolreza Norouzy or Mahdi Shadnoush.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee of Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1397.141) and Semnan University of Medical Sciences and Health Services (IR.SEMUMS.REC.1397.001) has approved the protocol of this study. A written informed consent form will be signed and dated by subjects or their legal guardians and investigators at the beginning of the study.

Conflict of interests

The authors declared that they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zahedi, H., Hosseinzadeh-Attar, MJ., Sahebkar, A. et al. Therapeutic effects of supplementation with Curcuminoids in critically ill patients receiving enteral nutrition: a randomized controlled trial protocol. J Diabetes Metab Disord 19, 1609–1614 (2020). https://doi.org/10.1007/s40200-019-00451-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-019-00451-w

Keywords

Navigation